创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Evaluation and Risk Control of Idiosyncratic Liver Injury Caused by Traditional Chinese Medicine
BAI Zhaofang, GAO Yuan, WANG Jiabo, XIAO Xiaohe
2020, 44(10): 724-729.
Abstract PDF
Research Progress of Chinese Materia Medicainduced Cardiotoxicity
PAN Xiaoqi, YAN Bohua, ZHOU Jie, CAO Xiaoyu, PENG Cheng
2020, 44(10): 730-742.
Abstract PDF
Influence Factors and Prevention and Treatment Strategies of Chinese Herbal Medicine-related Renal Damage
XIE Yuansheng
2020, 44(10): 743-751.
Abstract PDF
Thoughts on the Related Issues of Hypersensitivity Evaluation and Risk Control of Traditional Chinese Medicine Injection
LIANG Aihua, YI Yan
2020, 44(10): 752-758.
Abstract PDF
Advances in the Research on Safety of Traditional Medicine Containing Heavy Metals
WEI Lixin, ZHANG Boli
2020, 44(10): 759-765.
Abstract PDF
Progress in Research on Drug Targets in China (II)
JIANG Zhenzhou, YUAN Zihang, SUN Lixin, WU Qipeng, CHAI Yuanyuan, LI Sijia, XIANG Ting, YU Qiongna, ZHU Ying, ZHANG Luyong
2020, 44(10): 766-789.
Abstract PDF
Advances in the Research on Biased Ligands of Cannabinoid Receptors
PEI Fangning, YANG Fan, TANG Jie, YU Lifang
2020, 44(10): 790-800.
Abstract PDF